SARS-CoV-2 T-cell Peptide Antigens set
SARS-CoV-2 T-cell Peptide Antigens set
Identified from in silico studies, the set of 6 peptides offered are unique T-cell epitopes from the SARS-CoV-2 spike protein sequence. The peptide sequences are offered in net peptide quantities in individual vials of 0.25 mg each. The sequences in the set are,CV2-1 YLQPRTFLL CV2-2 GVYFASTEK CV2-3 KLPDDFTGCV CV2-4 SIIAYTMSL CV2-5 NYNYLYRLFR CV2-6 GYLQPRTFLL
Online Inquiry
| Size | 0.25 mg NET peptide |
Storage | -20°C |
References | 1. Ahmed SF et al. Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies. Viruses. 2020 Mar;12(3):254. 2. Baruah V, & Bose S. Immunoinformatics‐aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019‐nCoV. Journal of medical virology. 2020 May;92(5):495-500. 3. Grifoni A et al. A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2. Cell host & microbe. 2020 Mar 16. 4. Coutard B et al. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral research. 2020 Apr 1;176:104742. 5. Kiyotani K et al. Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2. Journal of Human Genetics (2020) 65:569–575 |
Write a review
Ask a question
My Review for SARS-CoV-2 T-cell Peptide Antigens set
Required fields are marked with *
×
Ask a Question for SARS-CoV-2 T-cell Peptide Antigens set
Required fields are marked with *
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
